Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 5-(3-hydroxy-2-hydroxymethylpropionamido)-n,n'-dimethyl-n,n'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide
2. Xenetix
1. 136949-58-1
2. Xenetix
3. 182ech14uh
4. 1-n,3-n-bis(2,3-dihydroxypropyl)-5-[[3-hydroxy-2-(hydroxymethyl)propanoyl]amino]-2,4,6-triiodo-1-n,3-n-dimethylbenzene-1,3-dicarboxamide
5. N,n'-bis(2,3-dihydroxypropyl)-5-(2-(hydroxymethyl)hydracrylamido)-2,4,6-triiodo-n,n'-dimethylisophthalamide
6. Chebi:31701
7. 1,3-benzenedicarboxamide, N,n'-bis(2,3-dihydroxypropyl)-5-((5-hydroxy-2-(hydroxymethyl)-1-oxopropyl)amino)-2,4,6-triiodo-n,n'-dimethyl-
8. Iobitridol [inn]
9. Xenetix 300
10. Iobitridol [inn:ban]
11. Unii-182ech14uh
12. Iobitridol [mi]
13. Iobitridol (jan/inn)
14. Iobitridol [jan]
15. Iobitridol [mart.]
16. Iobitridol [who-dd]
17. Schembl23057
18. Chembl2107212
19. Dtxsid90869865
20. Db12407
21. Ncgc00532516-01
22. 5-(3-hydroxy-2-hydroxymethylpropionamido)-n,n'-dimethyl-n,n'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide
23. Ft-0627244
24. D01181
25. J-006941
26. Q6062197
27. 1,3-benzenedicarboxamide, N1,n3-bis(2,3-dihydroxypropyl)-5-((3-hydroxy-2-(hydroxymethyl)-1-oxopropyl)amino)-2,4,6-triiodo-n1,n3-dimethyl-
28. 5-(3-hydroxy-2-(hydroxymethyl)-propionamido)-n,n'-dimethyl-n,n'-bis-(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide
29. 5-[3-hydroxy-2-(hydroxymethyl)-propionamido]-n-n -dimethyl-n-n -bis-(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide
30. N,n'-bis(2,3-dihydroxypropyl)-5-((3-hydroxy-2-(hydroxymethyl)-1-oxopropyl)amino)-2,4,6-triiodo-n,n'-dimethyl-1,3-benzenedicarboxamide
31. N,n'-bis(2,3-dihydroxypropyl)-5-{[3-hydroxy-2-(hydroxymethyl)propanoyl]amino}-2,4,6-triiodo-n,n'-dimethylbenzene-1,3-dicarboxamide
Molecular Weight | 835.2 g/mol |
---|---|
Molecular Formula | C20H28I3N3O9 |
XLogP3 | -3 |
Hydrogen Bond Donor Count | 7 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 12 |
Exact Mass | 834.8960 g/mol |
Monoisotopic Mass | 834.8960 g/mol |
Topological Polar Surface Area | 191 Ų |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 675 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Contrast Media
Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)
V08AB11
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
V - Various
V08 - Contrast media
V08A - X-ray contrast media, iodinated
V08AB - Watersoluble, nephrotropic, low osmolar x-ray contrast media
V08AB11 - Iobitridol
Global Sales Information
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?